# Glucagonlike Peptide-1 Receptor Agonists: The Good, the Bad, and the Ugly—Benefits for Glucose Control and Weight Loss with Side Effects of Delaying Gastric Emptying

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/glucagonlike-peptide-1-receptor-agonists-the-good-the-bad-and-the-ugly-benefits/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Henry P. Parkman,Daniel Rim,Jonathan Anolik,Simin Dadparvar,Alan H. Maurer |
| Citations | 18 |
| DOI | 10.2967/jnmt.123.266800 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://tech.snmjournals.org/content/jnmt/52/1/3.full.pdf |
| OpenAlex ID | https://openalex.org/W4390699803 |
| PMID | 38443105 |
| Type | article |
| Year | 2024 |

## Paper authors

- [Daniel Rim](https://scholariq.org/researchers/daniel-rim/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Pharmacology and Obesity Treatment](https://scholariq.org/topics/pharmacology-and-obesity-treatment/)
- [Bariatric Surgery and Outcomes](https://scholariq.org/topics/bariatric-surgery-and-outcomes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.